Self-Assembled Micellar Glutaminase Allosteric Inhibitor for Effective Therapeutic Intervention

References

• Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19(1):annurev-bioeng-071516-044546. doi:10.1146/annurev-bioeng-071516-044546
   PubMed Web of Science ®Google Scholar
• Xu X, Meng Y, Li L, et al. Overview of the development of glutaminase inhibitors: achievements and future directions. J Med Chem. 2019;62(3):1096–1115. doi:10.1021/acs.jmedchem.8b00961
   PubMed Web of Science ®Google Scholar
• Wise D, Thompson C. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427–433. doi:10.1016/j.tibs.2010.05.003
   PubMed Web of Science ®Google Scholar
• Erickson JW, Cerione RA. Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget. 2010;1:734–740. doi:10.18632/oncotarget.208
   PubMed Web of Science ®Google Scholar
• Li L, Meng Y, Li Z, et al. Discovery and development of small molecule modulators targeting glutamine metabolism. Eur J Med Chem. 2019;163:215–242. doi:10.1016/j.ejmech.2018.11.066
   PubMed Web of Science ®Google Scholar
• Gordon EB, Hart GT, Tran TM, et al. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proc Natl Acad Sci USA. 2015;112:13075–13080. doi:10.1073/pnas.1516544112
   PubMed Web of Science ®Google Scholar
• Leone RD, Zhao L, Englert JM, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366(6468):1013–1021. doi:10.1126/science.aav2588
   PubMed Web of Science ®Google Scholar
• Krupa S, Ferraris DV, Thomas AG, et al. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) analogs as glutaminase inhibitors. J Med Chem. 2012;55(23):10551–10563. doi:10.1021/jm301191p
   PubMed Web of Science ®Google Scholar
• Gross MI, Demo SD, Dennison JB, Chen L, Bennett MK. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13(4):890–901. doi:10.1158/1535-7163.MCT-13-0870
   PubMed Web of Science ®Google Scholar
• Chen Z, Li D, Xu N, et al. Novel 1,3,4-Selenadiazole-containing kidney-type glutaminase inhibitors showed improved cellular uptake and antitumor activity. J Med Chem. 2019;62(2):589–603. doi:10.1021/acs.jmedchem.8b01198
   PubMed Web of Science ®Google Scholar
• Soth MJ, Le K, Francesco MED, et al. Discovery of IPN60090, a clinical stage selective glutaminase-1 (GLS-1) inhibitor with excellent pharmacokinetic and physicochemical properties. J Med Chem. 2020;63(21):12957–12977. doi:10.1021/acs.jmedchem.0c01398
   PubMed Web of Science ®Google Scholar
• Vartak R, Patki M, Menon S, et al. β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV. Int J Pharmaceutics. 2020;589:119863. doi:10.1016/j.ijpharm.2020.119863
   PubMed Web of Science ®Google Scholar
• Elgogary A, Xu Q, Poore B, et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci USA. 2016;113(36):E5328–5336. doi:10.1073/pnas.1611406113
   PubMed Web of Science ®Google Scholar
• Giesen B, Nickel AC, Barthel J, Kahlert UD, Janiak C. Augmented therapeutic potential of glutaminase inhibitor CB839 in glioblastoma stem cells using gold nanoparticle delivery. Pharmaceutics. 2021;13:295. doi:10.3390/pharmaceutics13020295
   PubMed Web of Science ®Google Scholar
• Zhu M, Fang J, Zhang J, et al. Biomolecular interaction assays identified dual inhibitors of glutaminase and glutamate dehydrogenase that disrupt mitochondrial function and prevent growth of cancer cells. Anal Chem. 2017;89(3):1689–1696. doi:10.1021/acs.analchem.6b03849
   PubMed Web of Science ®Google Scholar
• Ruan JJ, Yu Y, Hou W, et al. Kidney-Type Glutaminase inhibitor Hexylselen selectively kills cancer cells via a three-pronged mechanism. ACS Pharmacol Transl Sci. 2019;2(1):18–30. doi:10.1021/acsptsci.8b00047
   PubMedGoogle Scholar
• Fang J, Chen Z, Song J, et al. Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and in vivo antitumor efficacy of Hexylselen. RSC Chem Biol. 2021;2(6):1669–1681. doi:10.1039/D1CB00089F
   PubMedGoogle Scholar
• Pignatello R, Corsaro R. Polymeric nanomicelles of soluplus as a strategy for enhancing the solubility, bioavailability and efficacy of poorly soluble active compounds. Curr Nanomed. 2019;09(3):184–197. doi:10.2174/2468187309666190314152451
   Google Scholar
• Obata T, Suzuki Y, Ogawa N, et al. Improvement of the antitumor activity of poorly soluble sapacitabine (CS-682) by using Soluplus as a surfactant. Biol Pharm Bull. 2014;37(5):802–807. doi:10.1248/bpb.b13-00898
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot EM, Djuric D, et al. Soluplus as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 2012;45(3):336–343. doi:10.1016/j.ejps.2011.11.025
   PubMed Web of Science ®Google Scholar
• Sachan N, Bhattacharya A, Pushkar S, Mishra A. Biopharmaceutical classification system: a strategic tool for oral drug delivery technology. Asian J Pharm. 2009;3(2):76–81. doi:10.4103/0973-8398.55042
   Google Scholar
• Quan G, Niu B, Singh V, et al. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement. Int J Nanomed. 2017;12:8801–8811. doi:10.2147/IJN.S149717
   PubMed Web of Science ®Google Scholar
• Alopaeus JF, Hagesæther E, Tho I. Micellisation mechanism and behaviour of soluplus®–furosemide micelles: preformulation studies of an oral nanocarrier-based system. Pharmaceuticals. 2019;12(1):15. doi:10.3390/ph12010015
   Web of Science ®Google Scholar
• Zeng YC, Li S, Liu C, et al. Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic. Acta Pharmacol Sin. 2017;38:424–433. doi:10.1038/aps.2016.126
   PubMed Web of Science ®Google Scholar
• Nandi U, Ajiboye AL, Patel P, Douroumis D, Trivedi V. Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement. Pharmaceuticals. 2021;14(9):846. doi:10.3390/ph14090846
   Web of Science ®Google Scholar
• Zhang Y, Liu Y, Luo Y, et al. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. Drug Deliv. 2016;23(6):1902–1911. doi:10.3109/10717544.2014.960982
   PubMed Web of Science ®Google Scholar
• Salawi A, Nazzal S. The physiochemical, mechanical, and adhesive properties of solvent-cast vitamin E Soluplus(R) films. Int J Pharmaceutics. 2018;552(1–2):378–387. doi:10.1016/j.ijpharm.2018.10.018
   PubMed Web of Science ®Google Scholar
• Salah I, Abou Shamat M, Cook MT. Soluplus solutions as thermothickening materials for topical drug delivery. J Appl Polym Sci. 2019;136(1):1–9. doi:10.1002/app.46915
   Web of Science ®Google Scholar
• Lee SY, Lee JJ, Park JH, et al. Electrosprayed nanocomposites based on hyaluronic acid derivative and soluplus for tumor-targeted drug delivery. Colloids Surf B Biointerfaces. 2016;45:267–274. doi:10.1016/j.colsurfb.2016.05.009
   Web of Science ®Google Scholar
• Ke Z, Zhang Z, Wu H, Jia X, Wang Y. Optimization and evaluation of oridonin-loaded Soluplus (R)-Pluronic P105 mixed micelles for oral administration. Int J Pharmaceutics. 2017;18(1–2):193–202. doi:10.1016/j.ijpharm.2016.12.047
   Web of Science ®Google Scholar
• Hou J, Sun E, Sun C, et al. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus®-Solutol® HS15 binary mixed micelles system. Int J Pharmaceutics. 2016;12:186–193. doi:10.1016/j.ijpharm.2016.08.045
   Web of Science ®Google Scholar
• Zhu C, Gong S, Ding J, et al. Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus–PVPVA complex. Acta Pharmaceutica Sinica B. 2019;9(1):107–117. doi:10.1016/j.apsb.2018.09.004
   PubMed Web of Science ®Google Scholar
• Dian L-H, Hu Y-J, Lin J-Y, et al. Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. Int J Nanomed. 2018;13:719–731. doi:10.2147/IJN.S150140
   PubMed Web of Science ®Google Scholar
• Ting JM, Porter WW, Mecca JM, Bates FS, Reineke TM. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery. Bioconjugate Chem. 2018;29(4):339–952. doi:10.1021/acs.bioconjchem.7b00646
   Web of Science ®Google Scholar
• Zhang W, Zhu M, Wang F, et al. Mono-sulfonated tetrazolium salt based NAD(P)H detection reagents suitable for dehydrogenase and real-time cell viability assays. Anal Biochem. 2016;509:33–40. doi:10.1016/j.ab.2016.06.026
   PubMed Web of Science ®Google Scholar
• Rui J, Xu N, Yin J, et al. The EZMTT cell proliferation assay provides precise measurement for drug combinations and better correlation between in vitro and in vivo efficacy. Bioorg Med Chem Lett. 2020;30(11):127134. doi:10.1016/j.bmcl.2020.127134
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao Y, Zhu Y, et al. Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human. J Pharm Biomed Anal. 2016;119:166–174. doi:10.1016/j.jpba.2015.11.016
   PubMed Web of Science ®Google Scholar
• Di L, Feng B, Goosen TC, et al. A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development. Drug Metab Dispos. 2013;41(12):1975–1993. doi:10.1124/dmd.113.054031
   PubMed Web of Science ®Google Scholar
• Zeng YC, Li S, Liu C, et al. Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacol Sin. 2017;38:424–433.
   PubMed Web of Science ®Google Scholar
• Dhand C, Prabhakaran PP, Beuerman RW, Lakshminarayanan R, Dwivedid N, Ramakrishna S. Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery. RSC Adv. 2014;4:32673–32689. doi:10.1039/C4RA02861A
   Web of Science ®Google Scholar
• Razak SAA, Wahab HA, Fisol FA. Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: an Overview. Cancers. 2021;13(3):400. doi:10.3390/cancers13030400
   PubMed Web of Science ®Google Scholar
• Yang X, Zhu B, Dong T, et al. Interactions between an Anticancer Drug and Polymeric Micelles Based on Biodegradable Polyesters. Macromol Biosci. 2008;8(12):1116–1125. doi:10.1002/mabi.200800085
   PubMed Web of Science ®Google Scholar
• Gou J, Feng S, Xu H, et al. Decreased core crystallinity facilitated drug loading in polymeric micelles without affecting their biological performances. Biomacromolecules. 2015;16:2920–2929. doi:10.1021/acs.biomac.5b00826
   PubMed Web of Science ®Google Scholar